Turn Therapeutics Statistics
NASDAQ: TTRXHealthcareBiotechnologyUSD
12.10+0.46 (+3.95%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Turn Therapeutics by the numbers
Turn Therapeutics has a market capitalization of $367.4 million based on 30.37M shares outstanding. With trailing EPS of $-0.29, Turn Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 8.2% above its 50-day average and 89.8% above its 200-day average.
Average daily trading volume is 114.62K shares, or about $1.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
TTRX valuation vs. peer median
| Metric | TTRX | Peer median | Difference |
|---|---|---|---|
| Market cap | $367.45M | $363.06M | +1% |
| Avg. volume | 114.62K | 926.18K | -88% |
Peer median across 8 companies: IRD, GALT, FENC, ARCT, ENTA, KYTX, CCCC, RLMD.
Valuation
- Market cap
- $367.45M
- EPS (TTM)
- $-0.29
- Shares outstanding
- 30.37M
Price and trading
- Previous close
- 11.64
- Open
- 11.58
- Day range
- 11.31 – 13.03
- 52-week range
- 2.57 – 26.50
- 52-week change
- +72.86%
- Beta
- —
- Volume
- 175.74K
- Average volume
- 114.62K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 12, 2026
Additional statistics
- Market Cap
- 367.45M
- Forward Pe
- -80.67
- Eps
- -0.29
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 26.50
- Week52 Low
- 2.57
- Avg Volume
- 114.62K
- Shares Outstanding
- 30.37M
- Ma50
- 11.19
- Ma200
- 6.37
- Earnings Date
- Nov 12, 2026
- Pct From52w High
- -54.34%
- Pct From52w Low
- 370.82%